News

Founder of the Camden Coalition and a SDOH pioneer is looking to establish a primary care clinic in southern New Jersey.

As several COVID-19 vaccine candidates are now in the late phase of clinical trials, MHE is sharing a few stories that have covered the infamous virus' vaccine development journey.

Briana Contreras speaks with Dan Knecht, Vice President of Clinical Product at CVS Health about telehealth, patient access, CVS minute clinics and Path to Better Health.

Underrepresentation of blacks in clinical trials is garnering special attention.

Managed Healthcare Executive® (MHE) interviewed Jeff Hawkins, president and CEO of Truvian Sciences, about how Truvian received an Emergency Use Authorization (EUA) from FDA for Easy Check COVID-19 IgM/IgG antibody test.

As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. First of three parts. See more in our Surveys tab.

Providers are under immense financial pressure because of COVID-19. More than ever, health systems, hospitals and physician practices are assuming the role of a bank, financing the cost of healthcare.

A strong, up-to-date compliance program should be part of a healthcare company's risk management strategy.

Senior Vice President and Chief Pharmacy Officer for Optum Rx and member of the Managed Healthcare Executive® Editorial Advisory Board, David Calabrese, provides his commentary on the future of pharmacy care services after the coronavirus pandemic.

Where some see bloat and trendiness, others see nimbleness and responsiveness.

Study allays some concern that high-deductible health plans cause people to put off care, although authors urge caution in interpreting the results.

Dr. Deepak Bhatt presents results that show Vascepa cuts the risk for surgeries to restore blood flow to the heart by a third.

Practice Fusion case spotlights how technology can be corrupted by commercial interests.

Jagdish Khubchandani, a Health Science professor at Ball State University, provides tips and reminders to help keep one of the most vulnerable populations safe during the continuous battle of COVID-19. Some tips not only include frequent hand-washing and wearing masks, but getting enough sleep is also just as important.

Biosimilar misinformation takes many forms, some of it institutionalized in the form of word usage and some of it deliberately disparaging, 2 executives of Sandoz and Boehringer Ingelheim contend.

Companies are using rewards and ‘gamification’ to encourage patients to take their pills as prescribed.

The role of technology in response to COVID-19 is a tipping point for virtual behavioral health services, according to a recent Accenture report.

Medical professionals are often strapped for time and they experience immense pressure to stay on top of paperwork while simultaneously having to see and treat patients. Add late nights on call and long shifts to the equation, and one can begin to comprehend the high-stress nature of the job.

Three healthcare organizations provide models for managing the disease and keeping a close eye on the bottom line.

Dr. David Ho, who developed the HIV cocktail, has isolated antibodies he says could be used to create treatments for COVID-19.

MHE's Briana Contreras spoke with CEO of Scripta, Eric Levin. The two discussed the current state of the pharmacy benefit market and how the Scripta organization has been assisting its clients and their prescriptions prior to the COVID-19 pandemic and during.

A small study shows that "photobiomodulation" with red light results in improved color vision in people that are 40 and older. The light may improve the function of mitochondria.

By doubling down on digital investments that transform the workplace, organizations improve their workforce management through the end of the crisis and build up their digital capabilities for a promising future.

Healthcare has always been evolving, but now it's evolving more than ever. What has changed are the trends in the health/tech space, the challenges CEOs are facing, and ways brands are improving convenience for the consumer.

The drug is the first treatment approved for active psoriatic arthritis that selectively inhibits interleukin (IL)-23.

The PBM overcharged for generic drugs, among other offenses, a new lawsuit claims.

University of Michigan researchers developed a simple algorithm to guide risk-benefit decisions for glaucoma patient coming in for visits.

When Medicaid pays for food, it helps prevent chronic disease.

An experimental coronavirus vaccine called AZD1222 triggered an immune response against COVID-19 in study participants, and it has only minor side effects.